GLAXOSMITHKLINE's ticker is and the CUSIP is 0925288. A total of 1 filers reported holding GLAXOSMITHKLINE in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $793,000 | -0.5% | 37,160 | 0.0% | 0.04% | -6.5% |
Q2 2016 | $797,000 | -93.3% | 37,160 | -93.7% | 0.05% | -93.2% |
Q1 2016 | $11,892,000 | +2.1% | 585,950 | +1.8% | 0.67% | +2.7% |
Q4 2015 | $11,649,000 | +5.3% | 575,655 | -0.2% | 0.66% | -3.0% |
Q3 2015 | $11,066,000 | -11.3% | 577,045 | -3.8% | 0.68% | +2.0% |
Q2 2015 | $12,479,000 | -9.2% | 599,960 | +0.2% | 0.66% | -9.7% |
Q1 2015 | $13,742,000 | +7.5% | 598,775 | +0.5% | 0.73% | +2.4% |
Q4 2014 | $12,786,000 | -7.0% | 595,920 | -0.7% | 0.72% | -6.6% |
Q3 2014 | $13,742,000 | -12.8% | 599,915 | +1.7% | 0.77% | -10.8% |
Q2 2014 | $15,767,000 | +8.2% | 589,605 | +7.4% | 0.86% | +4.4% |
Q1 2014 | $14,571,000 | +2.5% | 549,175 | +3.1% | 0.82% | +3.9% |
Q4 2013 | $14,217,000 | +28.8% | 532,675 | +21.7% | 0.79% | +24.5% |
Q3 2013 | $11,036,000 | +2.3% | 437,535 | +1.4% | 0.64% | -5.1% |
Q2 2013 | $10,785,000 | – | 431,500 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boston Common Asset Management, LLC | 549,175 | $14,571,000 | 0.82% |